drugset / Trial / NCT01171092
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma
Phase 0
Completed
21 enrolled
University of Kansas Medical Center
Millennium Pharmaceuticals, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the combination of G-CSF and bortezomib is safe and effective in blood cell mobilization.
Timeline
- Start
- 2010-09
- Primary completion
- 2013-01
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | 1.3 mg/m2 | — |
| Subject | G-CSF | Unknown | 10 ug/kg | Subcutaneous |